The two U.S. markets regulators will have a joint event to highlight their unified crypto agenda, following the arrival of ...

Key Insights Significant control over FinWise Bancorp by individual investors implies that the general public has ...

Shares of BitGo (BTGO), which went live on the New York Stock Exchange (NYSE) on Thursday, are down 12% midday on Friday, ...

JetBlue Airways (JBLU) is back in focus after Jim Cramer criticized its recent earnings and outlook, following a single ...

Sangamo Therapeutics is back in focus as the latest price target reset gives investors fresh clues about how the story around this gene therapy name is evolving. With the prior target now withdrawn ...

IRS Direct File, which was offered in 25 states last year, has been discontinued. But one very-much underused, free program ...

Business leaders, as a result, are becoming anxious about the blowback — even as they rhapsodize about the coming AI ...

Why recent management commentary matters for Molina Healthcare (MOH) Recent commentary from Molina Healthcare (MOH) ...

If you are wondering whether Bristol-Myers Squibb is offering good value at around US$54.94 per share, you are not alone.

Granules India Ltd (BOM:532482) reports a robust 22% revenue increase, regulatory milestones, and strategic focus on ...

After President Trump scrapped planned tariffs on European allies, easing worries about a transatlantic trade clash, ...

What Brookfield’s recent share performance tells you Brookfield (TSX:BN) has seen mixed returns recently, with a small gain ...